Apellis Pharmaceuticals Inc (APLS)

Apellis Pharmaceuticals Inc Azioni (APLS) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	32.59% 146.38	110.40	94.97	44.85	22.66
Operating Expenses	6.70% 230.90	247.48	215.41	219.93	186.72
Benefits Costs and Expenses	6.74% 233.53	250.40	216.81	222.34	190.12
Costs And Expenses	6.74% 233.53	250.40	216.81	222.34	190.12
Operating Income/Loss	38.34% -84.52	-137.08	-120.44	-175.08	-164.05
Income/Loss From Continuing Operations Before Tax	37.75% -87.15	-140.00	-121.84	-177.50	-167.46
Income Tax Expense/Benefit	510.73% 1.423	0.233	0.194	0.282	-1.471
Income/Loss From Continuing Operations After Tax	36.84% -88.58	-140.24	-122.04	-177.78	-165.99
Net Income/Loss	36.84% -88.58	-140.24	-122.04	-177.78	-165.99
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98,460% 118.56	0.1203	0.1193	0.1139	106.01
Diluted Average Shares	98,460% 118.56	0.1203	0.1193	0.1139	106.01
Basic Earnings Per Share	38.46% -0.72	-1.17	-1.02	-1.56	-1.50
Diluted Earnings Per Share	38.46% -0.72	-1.17	-1.02	-1.56	-1.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-